3Sbio (01530) announced interim results

• RevenueRMB45.3bn
• Net profitRMB12.1bn
• Profit attributable to ownersRMB11.5bn
• Revenue YoY+3.9%
• Net profit YoY-12.9%
• Depreciation & amortisationHK$5.4bn
• Capital expenditureHK$-5.4bn
• Interest-bearing debtHK$26.2bn

Source 3Sbio